CN100559973C - Cyster zinc sypplementing agent and preparation method thereof - Google Patents
Cyster zinc sypplementing agent and preparation method thereof Download PDFInfo
- Publication number
- CN100559973C CN100559973C CNB200610047246XA CN200610047246A CN100559973C CN 100559973 C CN100559973 C CN 100559973C CN B200610047246X A CNB200610047246X A CN B200610047246XA CN 200610047246 A CN200610047246 A CN 200610047246A CN 100559973 C CN100559973 C CN 100559973C
- Authority
- CN
- China
- Prior art keywords
- zinc
- sypplementing
- cyster
- oyster
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 title claims abstract description 78
- 239000011701 zinc Substances 0.000 title claims abstract description 78
- 229910052725 zinc Inorganic materials 0.000 title claims abstract description 78
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims description 15
- 241000237502 Ostreidae Species 0.000 claims abstract description 26
- 235000020636 oyster Nutrition 0.000 claims abstract description 26
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 claims abstract description 23
- 235000006076 zinc citrate Nutrition 0.000 claims abstract description 23
- 239000011746 zinc citrate Substances 0.000 claims abstract description 23
- 229940068475 zinc citrate Drugs 0.000 claims abstract description 23
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000000463 material Substances 0.000 claims abstract description 16
- 229960003080 taurine Drugs 0.000 claims abstract description 11
- 239000004480 active ingredient Substances 0.000 claims abstract description 10
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 4
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 38
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 19
- 239000011726 vitamin B6 Substances 0.000 claims description 19
- 235000019158 vitamin B6 Nutrition 0.000 claims description 19
- 229940011671 vitamin b6 Drugs 0.000 claims description 19
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims description 16
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims description 16
- 235000013372 meat Nutrition 0.000 claims description 11
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 10
- 235000013734 beta-carotene Nutrition 0.000 claims description 10
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 10
- 239000011648 beta-carotene Substances 0.000 claims description 10
- 229960002747 betacarotene Drugs 0.000 claims description 10
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 10
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 9
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 9
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 9
- 235000019155 vitamin A Nutrition 0.000 claims description 9
- 239000011719 vitamin A Substances 0.000 claims description 9
- 229940045997 vitamin a Drugs 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 230000003068 static effect Effects 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 238000010009 beating Methods 0.000 claims description 5
- 108091005804 Peptidases Proteins 0.000 claims description 4
- 239000004365 Protease Substances 0.000 claims description 4
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 238000000643 oven drying Methods 0.000 claims description 3
- 239000002002 slurry Substances 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 238000000354 decomposition reaction Methods 0.000 claims description 2
- 238000005469 granulation Methods 0.000 claims description 2
- 230000003179 granulation Effects 0.000 claims description 2
- 238000012856 packing Methods 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 230000001079 digestive effect Effects 0.000 claims 2
- 238000001035 drying Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 13
- 235000013305 food Nutrition 0.000 abstract description 6
- 230000009469 supplementation Effects 0.000 abstract description 5
- 238000003786 synthesis reaction Methods 0.000 abstract description 4
- 210000002569 neuron Anatomy 0.000 abstract description 3
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 abstract description 2
- 238000010521 absorption reaction Methods 0.000 abstract description 2
- 230000008485 antagonism Effects 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- 229910001385 heavy metal Inorganic materials 0.000 abstract description 2
- 102000039446 nucleic acids Human genes 0.000 abstract description 2
- 108020004707 nucleic acids Proteins 0.000 abstract description 2
- 150000007523 nucleic acids Chemical class 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 23
- 238000001727 in vivo Methods 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 235000008935 nutritious Nutrition 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940091251 zinc supplement Drugs 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 239000011576 zinc lactate Substances 0.000 description 1
- 229940050168 zinc lactate Drugs 0.000 description 1
- 235000000193 zinc lactate Nutrition 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention relates to food, health products or medicine, Cyster zinc sypplementing agent is made up of active ingredient and auxiliary material, and active ingredient is mainly ostreae testa pulverata and zinc citrate.Zinc content of the present invention meets national regulation, and the source of zinc is from marine products zinc of oyster and artificial synthetic zinc citrate.Oyster is the highest food of zinc content, eats not hinder more, and the zinc chelating that it contains has easy absorption and safe characteristics in protein and nucleic acid, and the effect that it improves zinc dificiency is more outstanding than the zinc of chemical synthesis.Oyster also contains abundant taurine except that containing zinc.Taurine also is the indispensable material of nerve cell.Zinc citrate has the advantage that absorbability is good, bioavilability is high, but the also harm of heavy metals such as antagonism lead, pot after the zinc ion that zinc citrate is separated out is absorbed.The two yuan of changes in the source of zinc help bringing into play the effect of zinc supplementation.
Description
Technical field:
The present invention relates to food, health products or medicine, particularly relate to the mineral matter Zinc supplements, also relate to its preparation method in addition.
Background technology:
The general insufficiency of intake of Chinese mineral matter zinc, day per capita intake be 12.0 milligrams (Chinese Soclety of Nutrition formulate recommended amounts are 15 milligrams).Its main cause is the zinc undersupply in the meals.Therefore, replenish by the nutrient prime replenisher that contains zinc with regard to being necessary.The nutrient prime replenisher that contains zinc in the market is from mainly contain two big classes in form: one, compound, except that containing zinc, also contain other various trace elements, kind surplus reaching 20, as Amway nutrition sheet, 21 Jin Weita, gold partner, the product of this class form is replenishing outside the zinc, other multiple elements have also been replenished, although some product also includes vitamin B6 and vitamin A or the beta carotene in close relations with the zinc metabolism, it is irrelevant or concern unconspicuous other elements also to include other and zinc metabolism.The disadvantage of this series products is: if take for a long time, just cause certain element excess intake easily, may poison.Two, single type only contains zinc, does not contain other compositions, and the product of this type of form has been ignored two facts, and the one, there is synergistic each other principle in vivo in some nutrients; The 2nd, considerable Chinese residents also lacks the trace element of some other kind when lacking zinc.
From raw material sources, the raw material of Zinc supplements product in the market all is artificial synthesis type.That is, mineral matter zinc derives from zinc lactate, zinc gluconate or the zinc citrate etc. of artificial chemical synthesis.Though all having with the oyster meat both at home and abroad is the launch of raw material, still also of no use so far it makes feedstock production is the nutritious supplementary pharmaceutical of specific purpose with the zinc supplementation.
Summary of the invention:
The objective of the invention is to overcome the problems referred to above that above-mentioned zinc supplementation product exists, providing a kind of is the nutritious supplementary pharmaceutical of major function composition with the marine products zinc in the oyster, simultaneously, also contains artificial synthetic zinc citrate.The zinc that product contains is accomplished two yuan of changes, and is not only safe, action effect is good, can promote zinc to absorb and the composition that utilizes but also be combined with other, can strengthen zinc action intensity in vivo.Production method provided by the invention, simple, easy row.
The technical scheme that the present invention is adopted for achieving the above object is: Cyster zinc sypplementing agent is made up of active ingredient and auxiliary material, and active ingredient is mainly ostreae testa pulverata and zinc citrate.
The weight ratio of described active ingredient ostreae testa pulverata and zinc citrate is 30-90: 0.1-1.5.
Described active ingredient also comprises one or more in vitamin B6, beta carotene, the stachyose.
The batching of described Cyster zinc sypplementing agent is for ostreae testa pulverata, zinc citrate, vitamin B6, beta carotene, stachyose and auxiliary material with fresh oyster preparation, and is formulated in the ratio of 30-90: 0.1-1.5: 0.005-0.20: 0.002-0.15: 5-50: 15-65.
Described Cyster zinc sypplementing agent is tablet or capsule.
Oyster zinc content is the 100-2000 milligram in the per 100 gram products of described final products, and zinc citrate is the 100-1000 milligram, and vitamin A is the 0.03-6.0 milligram, and vitamin B6 is the 0.05-5 milligram, and taurine is the 0.1-2 gram, and stachyose is the 10-50 gram.
The preparation method of described Cyster zinc sypplementing agent is:
The preparation of ostreae testa pulverata: choose, clean oyster, remove silt, strip oyster meat, behind the excision enteron aisle and the cheek, body meat is ground making beating, add protease, static 1-10 hour, put 60-75 ℃ of hot-air oven drying, pulverizing, cross 80 mesh sieves, unsifted part is pulverized the back after sieve, and until passing through 90%, it is standby to make ostreae testa pulverata.
Preparation: by the prescription requirement, in ostreae testa pulverata, add other compositions, stir, add auxiliary material and suitable quantity of water or alcohol such as microcrystalline cellulose or starch, granulate, dry, encapsulated or compressing tablet, packing.
The present invention be directed to the nutritious supplementary pharmaceutical that generally lacks the design of mineral matter zinc in the Chinese residents meals, the zinc amount that contains meets national regulation (minimum 5 mg/day, maximum amount 20 mg/day).The source of zinc of the present invention has two, one, from the marine products zinc of oyster, and the 2nd, artificial synthetic zinc citrate.Oyster is the highest food of zinc content in the human foods, the bright oyster meat of per kilogram contains the 80-160 milligram, oyster is nutritious and the food liked very much, eats not hinder more, and the zinc chelating that it contains is in protein and nucleic acid, have easy absorption and safe characteristics, the effect that it improves zinc dificiency is more outstanding than the zinc of chemical synthesis, simultaneously, owing to adopted oyster to make main raw material, security of products can be ensured more fully.The critical function of zinc is the growth that promotes nerve cell, and brain-tonifying effect is arranged, and oyster also contains abundant taurine except that containing zinc.Taurine also is the indispensable material of nerve cell, therefore, makes raw material with oyster, and except that having two above advantages, taurine has wherein also been promoted the brain-tonifying effect of zinc.Zinc citrate is the zinc product of newly developing in recent years, has the advantage that absorbability is good, bioavilability is high, but the also harm of heavy metals such as antagonism lead, cadmium after the zinc ion that zinc citrate is separated out is absorbed.Zinc citrate is the main existence form of zinc in the man semen.Adopt zinc citrate and oyster zinc composite, can guarantee the set amount of zinc in the product, make two yuan of changes in source of zinc simultaneously, help bringing into play the effect of zinc supplementation, this point is particularly useful to male sex consumer.Two kinds of zinc have kept suitable ratio in product, more can bring into play zinc effect in vivo.This product has added vitamin B6 and beta carotene.Vitamin B6 participates in the activity of kind of enzyme surplus in the of 60 in the body, and zinc is the auxiliary composition of kind of biology enzyme surplus in the of 200 in the human body, so the activity in enzyme system of vitamin B6 and zinc can be complemented each other, studies show that, vitamin B6 has and promotes and the function of reinforcement zinc effect.After beta carotene is absorbed, can be converted into vitamin A in vivo, and vitamin A a kind of vitamin that to be China resident seriously lack has complementary and synergistic effect with zinc in metabolism, both sides relation is close.Why the present invention selects the precursor beta carotene of vitamin A, is because its security exceeds vitamin A.Studies confirm that vitamin B6, these two kinds of vitamins of vitamin A and zinc have collaborative mutually effect in people's body.And this point just is being ignored of many zinc supplementation products now.Added stachyose in this product, stachyose is a kind of compound sugar of latest domestic research and development, in the enteron aisle Bifidobacterium under the effect of stachyose, can breed fast, and produce various water soluble vitamins in a large number, wherein just comprise vitamin B6, added the input amount that stachyose can reduce vitamin B6.Simultaneously, stachyose has good cohesive, possesses the adhesive function, can substitute part tablet or capsule auxiliary material.Show that through the Wistar rat test zinc uptake of throwing the experimental group animal that gives this product is significantly higher than blank treated animal and the positive control treated animal that gives certain commercially available Zinc supplements, statistical analysis significant difference.
The specific embodiment:
The present invention is described in further detail below in conjunction with the specific embodiment, but be not limited to specific embodiment.
Embodiment 1
Preparation ostreae testa pulverata: oyster meat is cut; select liver pancreas position for use; grind making beating, add protein decomposition enzyme, static 2-6 hour; get the relative higher interval slurries of zinc content with taurine; 60-75 ℃ of hot-air oven baking is dry, pulverizes 80 mesh sieves, and unsifted part is pulverized the back after sieve; until passing through 90%, it is standby to get ostreae testa pulverata.
Preparation: in ostreae testa pulverata, add other active ingredients and auxiliary material by following weight, stir, granulation, compressing tablet get the Cyster zinc sypplementing agent tablet.
Ostreae testa pulverata 90kg
Zinc citrate 1kg
Supplementary product starch, sucrose 20kg.
Embodiment 2
Preparation ostreae testa pulverata: choose, clean oyster, remove silt, strip 100 kilograms of oyster meats; extract the enteron aisle and the cheek; select oyster liver pancreas position for use, meat is ground making beating, add protease; static 1-10 hour; get the relative higher interval slurries of zinc content, heat release wind oven drying, pulverized 70 mesh sieves, unsifted part is pulverized the back after sieve with taurine; until passing through 90%, it is standby to get 16 kilograms of ostreae testa pulveratas.
Preparation: by following prescription (unit kilogram) requirement, in ostreae testa pulverata, add vitamin B6, stachyose, fill and part stir, add auxiliary material matter and an amount of alcohol such as cellulose, granulate, encapsulated, pack capsule.
Ostreae testa pulverata 16
Zinc citrate 0.5
Vitamin B6 5
Stachyose 15
Auxiliary material 10.
Embodiment 3
Produce the Cyster zinc sypplementing agent tablet according to embodiment 1 described method, raw materials used and fill a prescription (kg) is as follows,
Ostreae testa pulverata 30
Zinc citrate 0.05
Vitamin B6 0.55
Beta carotene 5
Stachyose 10
Auxiliary material 20.
Embodiment 4
Produce the Cyster zinc sypplementing agent capsule according to embodiment 1 described method, raw materials used and fill a prescription (kg) is as follows,
Ostreae testa pulverata 80
Zinc citrate 0.6
Vitamin B6 0.8
Beta carotene 1.2
Stachyose 16
Auxiliary material 25.
Cyster zinc sypplementing agent tablet of the present invention and capsule are the 100-2000 milligrams by oyster zinc content in the per 100 gram products of final products generally; zinc citrate is the 100-1000 milligram; vitamin A is the 0.03-6.0 milligram; vitamin B6 is the 0.05-5 milligram; taurine is a 0.1-2 gram, and stachyose is that 10-50 restrains and sets.
Claims (5)
1, Cyster zinc sypplementing agent, it is characterized in that: it is made up of active ingredient and auxiliary material, active ingredient is ostreae testa pulverata and zinc citrate, vitamin B6, beta carotene and stachyose, auxiliary material is cellulose, starch or sucrose, the batching of described Cyster zinc sypplementing agent is ostreae testa pulverata, zinc citrate, vitamin B6, beta carotene, stachyose and auxiliary material, and is formulated in the ratio of 30-90: 0.1-1.5: 0.005-0.20: 0.002-0.15: 5-50: 15-65.
2, Cyster zinc sypplementing agent according to claim 1 is characterized in that: Cyster zinc sypplementing agent is tablet or capsule.
3, Cyster zinc sypplementing agent according to claim 1; it is characterized in that: oyster marine products zinc content is the 100-2000 milligram in the per 100 gram products of Cyster zinc sypplementing agent; the content of zinc citrate is the 100-1000 milligram; vitamin A is the 0.03-6.0 milligram; vitamin B6 is the 0.05-5 milligram; taurine is the 0.1-2 gram, and stachyose is the 10-50 gram.
4, the preparation method of the arbitrary described Cyster zinc sypplementing agent of claim 1-3 is characterized in that:
The preparation of ostreae testa pulverata: choose, clean oyster, remove silt, strip oyster meat, behind the excision glandula digestive and the cheek, body meat is ground making beating, add protease, static 1-10 hour, heat release wind oven drying, pulverizing, mistake 80 mesh sieves were pulverized the back after sieve with unsifted part, until passing through 90%, it is standby to get ostreae testa pulverata;
Preparation: by concrete composition of raw materials, in ostreae testa pulverata, add other active ingredients except that ostreae testa pulverata, stir, add auxiliary material and suitable quantity of water or alcohol, granulation, oven dry, encapsulated or compressing tablet, packing.
5, the preparation method of Cyster zinc sypplementing agent according to claim 4; it is characterized in that: being prepared as of ostreae testa pulverata: clean and win oyster meat; after extracing the glandula digestive and the cheek, body meat is ground making beating, add protease; static 1-10 hour; add protein decomposition enzyme, static 1-10 hour, get the relative higher interval slurries of zinc content with taurine; behind 60-75 ℃ of hot-air oven inner drying, pulverize, make ostreae testa pulverata.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200610047246XA CN100559973C (en) | 2006-07-17 | 2006-07-17 | Cyster zinc sypplementing agent and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200610047246XA CN100559973C (en) | 2006-07-17 | 2006-07-17 | Cyster zinc sypplementing agent and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1899119A CN1899119A (en) | 2007-01-24 |
| CN100559973C true CN100559973C (en) | 2009-11-18 |
Family
ID=37655255
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB200610047246XA Active CN100559973C (en) | 2006-07-17 | 2006-07-17 | Cyster zinc sypplementing agent and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100559973C (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102475266A (en) * | 2010-11-22 | 2012-05-30 | 河北农业大学 | Preparation method of natural zinc-rich oyster powder |
| CN102174073A (en) * | 2010-12-17 | 2011-09-07 | 中国海洋大学 | Oyster protein peptide and zinc chelate and method for preparing same |
| CN103039995A (en) * | 2012-12-20 | 2013-04-17 | 苏州天南星生物科技有限公司 | Health-care food |
| CN106690171A (en) * | 2017-01-04 | 2017-05-24 | 广州聚澜健康产业研究院有限公司 | Zinc-enriched blood-tonifying lotus root starch |
| CN106666536A (en) * | 2017-01-04 | 2017-05-17 | 广州聚澜健康产业研究院有限公司 | Biological zinc supplement |
| CN108618153A (en) * | 2018-04-11 | 2018-10-09 | 钦州学院 | One seed oyster selenium-enriched protein powder lozenge |
| CN110916113A (en) * | 2019-12-13 | 2020-03-27 | 河北鹑暖花开食品有限公司 | Preparation method of oyster eggs |
| CN111955743A (en) * | 2020-08-28 | 2020-11-20 | 山东道道生物工程有限公司 | Dietary supplement containing modified oyster shell and preparation method thereof |
-
2006
- 2006-07-17 CN CNB200610047246XA patent/CN100559973C/en active Active
Non-Patent Citations (2)
| Title |
|---|
| 牡蛎冲剂的研制. 张部昌等.食品工业科技，第3期. 1998 |
| 牡蛎冲剂的研制. 张部昌等.食品工业科技，第3期. 1998 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1899119A (en) | 2007-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100559973C (en) | Cyster zinc sypplementing agent and preparation method thereof | |
| CN101731475B (en) | Compound feed suitable for juvenile fish of myxocyprinus asiaticus | |
| CN103750048B (en) | A kind of fermentation nonreactive crucian small fish coordinates hard pellet diet and preparation method thereof | |
| CN103750047B (en) | A kind of nonreactive micro mist slaking loach coordinates hard pellet diet and preparation method thereof | |
| CN101642197B (en) | Feeds for feeding Takifugu obscurus and preparation method thereof | |
| CN101156659A (en) | Organic swine core premix | |
| CN104489409A (en) | Experimental macaque feed and feeding method thereof | |
| CN103300244A (en) | Method for preparing high-efficiency laying hen feed | |
| CN102987161A (en) | Broiler feed without containing antibiotics | |
| CN102696912A (en) | Selenium-rich compound hard pellet feed for polyculture fishes and preparation method thereof | |
| CN102406084A (en) | Duck feed rich in organic selenium as well as preparation method and application thereof | |
| CN108201025A (en) | A kind of multifilament cray feed and preparation method thereof | |
| CN104605270A (en) | Wheat germ soluble granules, and preparation method thereof | |
| CN104782980A (en) | Intestine-protecting non-tolerant efficient puffing granular compound herring feed and preparation method thereof | |
| CN102028113A (en) | Process for preparing daily ration of beef cattle for producing functional beef | |
| CN102948642A (en) | Compound feed for meat-type breeding duck in egg producing period and preparation method thereof | |
| CN103202403A (en) | Feed for raising Jinghong breeder cock | |
| CN101744147A (en) | Compound feed for seawater white pomfret | |
| CN102960556B (en) | Young oplopanax elatus feed mainly prepared from enteromorpha and preparation method and feeding method thereof | |
| CN102835565A (en) | Feed supplement promoting exuviate of prawns | |
| CN106360088A (en) | Green feed additive with function of improving chicken immunity and preparation method of green feed additive | |
| CN109548957A (en) | A kind of dragon design spot parent population nutrient enrichment fodder and preparation method thereof | |
| CN104782979A (en) | Fermented non-tolerant bleeding-preventing hard granular compound adult parabramis pekinensis feed and preparation method thereof | |
| CN102987166B (en) | Wheat type concentrated feed for layers during egg production peak hours and preparation method thereof | |
| CN106260744A (en) | A kind of fresh-water fishes ecologic breeding feedstuff |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee |
Owner name: DALIAN HAIBAO BIOTECHNOLOGY CO., LTD. Free format text: FORMER NAME: TAIINGYANG HAILONG SCIENCE AND TECHNOLOGY CO., LTD., DALIAN |
|
| CP01 | Change in the name or title of a patent holder |
Address after: Dalian Lushun 116045 export of Liaoning province Tieshan District Zhen Bai Lanzi Village Patentee after: Dalian Haibao Biological Technology Co., Ltd. Address before: Dalian Lushun 116045 export of Liaoning province Tieshan District Zhen Bai Lanzi Village Patentee before: Taiingyang Hailong Science and Technology Co., Ltd., Dalian |
|
| C56 | Change in the name or address of the patentee | ||
| CP01 | Change in the name or title of a patent holder |
Address after: Dalian Lushun 116045 export of Liaoning province Tieshan District Zhen Bai Lanzi Village Patentee after: Dalian Haibao biological Polytron Technologies Inc Address before: Dalian Lushun 116045 export of Liaoning province Tieshan District Zhen Bai Lanzi Village Patentee before: Dalian Haibao Biological Technology Co., Ltd. |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20170302 Address after: Dalian Lushun 116045 street Tieshan District Liaoning province Bai Lanzi Village No. 1 Patentee after: Dalian Hai Bao Biotechnology Co. Ltd. Address before: Dalian Lushun 116045 export of Liaoning province Tieshan District Zhen Bai Lanzi Village Patentee before: Dalian Haibao biological Polytron Technologies Inc |
|
| CP02 | Change in the address of a patent holder |
Address after: Dalian Lushun 116045 street Tieshan District Liaoning province Bai Lanzi Village No. 1 Patentee after: Dalian Hai Bao Biotechnology Co. Ltd. Address before: Dalian City, Liaoning Province in Lushun district Tieshan street Lanzi Bai Village No. 1 Patentee before: Dalian Hai Bao Biotechnology Co. Ltd. |
|
| CP02 | Change in the address of a patent holder |